Effect of Medicare Part D Benzodiazepine Exclusion on Psychotropic Use Among Benzodiazepine Users

類似資料

• Medicare Part D Benzodiazepine Exclusion and Use of Psychotropic Medication by Patients With New Anxiety Disorders
  著者:: Ong, Michael K., 等
  出版事項: (2012)
• Benzodiazepine Use and Expenditures for Medicare Beneficiaries and the Implications of Medicare Part D Exclusions
  著者:: Yang, Hui-wen Keri, 等
  出版事項: (2008)
• Medicare Part D’s Exclusion of Benzodiazepines and Fracture Risk in Nursing Homes
  著者:: Briesacher, Becky A., 等
  出版事項: (2010)
• Gabepentinoids and Benzodiazepines in Medicare Part D
  著者:: Weinhandl, Eric D.
  出版事項: (2018)
• Behavioral Health Treatment Patterns among Employer-Insured Adults in Same- and Different-Gender Marriages and Domestic Partnerships
  著者:: Tran, Linda Diem, 等
  出版事項: (2018)